logo
logo
Sign in

The Cell Surface Markers Detection Market Is Estimated To Witness High Growth Owing To Advancements In Digital Pathology Technologies

avatar
ashwini bakhade
The Cell Surface Markers Detection Market Is Estimated To Witness High Growth Owing To Advancements In Digital Pathology Technologies

The Cell Surface Markers Detection Market is estimated to be valued at US$ 5,459.5 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Cell surface markers detection helps in the identification and diagnosis of various cell types within a sample. Cell surface markers play an important role in identifying leukemia and lymphomas by determining stages and subtypes of diseases for targeted therapies. Technological advancements in flow cytometry and digital pathology are enabling analysis of multiple cell surface markers simultaneously, which delivers accurate disease diagnosis.

Market Key Trends:

One of the key trends in the cell surface markers detection market is the advancements in digital pathology technologies. Digital pathology uses a computer to convert glass slides into high-resolution digital slides that can be viewed, managed, shared and analyzed on monitors. Digital pathology enables analysis of a large number of cells and simultaneous detection of multiple cell surface markers through artificial intelligence and machine learning algorithms. This helps in accurate characterization of diseases and streamlines clinical workflows. Furthermore, incorporation of digital microscopy and whole slide imaging in routine diagnostics is enhancing the efficiency of cell surface markers detection procedures. The automated quantification and interpretations offered by digital pathology solutions are also fueling the growth of this market.

Porter’s Analysis

Threat of new entrants: The cell surface markers detection market requires high R&D investments and regulatory approvals which creates entry barriers for new players.

Bargaining power of buyers: The presence of several manufacturers gives buyers bargaining power in terms of price and availability of new advanced products.

Bargaining power of suppliers: The cell surface markers detection market has few raw material suppliers which gives them bargaining power over manufacturers.

Threat of new substitutes: There exist no close substitutes for cell surface markers detection techniques.

Competitive rivalry: The market is highly competitive with major players focusing on new product launches and geographic expansion.

SWOT Analysis

Strength: Established distribution channels and vast product portfolio of major players.Sensitivity and accuracy of cell surface markers detection techniques enable efficient disease diagnosis and management.

Weakness: High costs associated with R&D for development of new detection assays and instruments.Lack of skilled professionals hampers adoption of advanced detection systems in developing regions.

Opportunity: Untapped growth opportunities in emerging markets of Asia Pacific and Latin America due to increasing healthcare expenditure.Growing application of cell surface markers in in cancer immunotherapy and stem cell research.

Threats: Stringent regulatory framework for approval of new diagnostic devices and kits.Risks of technology obsolescence requires continual investments in innovation.

Key Takeaways

The Global Cell Surface Markers Detection Market Demand  is expected to witness high growth, exhibiting CAGR of 9.1% over the forecast period, due to increasing prevalence of chronic diseases like cancer and autoimmune disorders. North America dominates the market currently due to presence of major players and availability of advanced healthcare facilities while Asia Pacific region is expected fastest growing market during the forecast period.

Regional analysis

Asia Pacific region is projected to showcase the highest growth in the global cell surface markers detection market during the forecast period. This is attributed to growing healthcare sector, rising disposable incomes, increasing adoption of advanced diagnostic technologies driven by expanding medical tourism industry in countries like India and China.

Key players

Key players operating in the cell surface markers detection market includes Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others.

Rad More:

https://www.pressreleasebulletin.com/cell-surface-markers-detection-market-trends-insights-and-growth/

collect
0
avatar
ashwini bakhade
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more